Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2025-06-09 Major Shareholding Noti…
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a formal letter addressed to stock exchanges disclosing an inter-se transfer of shares between promoters of Alpa Laboratories Ltd. It references compliance with Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which pertains to disclosures of share acquisitions and transfers among promoters. The content includes details of the share transfer, the parties involved, and regulatory compliance statements. There are no financial statements, earnings data, or management discussion. The document is a regulatory disclosure about a share transfer event, specifically a promoter inter-se transfer, which fits the category of Major Shareholding Notification (MRQ). The document length is about 4994 characters, and it is not an announcement of a report but a direct disclosure filing. Therefore, the appropriate classification is MRQ with high confidence.
2025-06-09 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-06 English
Outcome of Board Meeting
Regulatory Filings
2025-05-28 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for May 28, 2025. The purpose of the meeting is to consider the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2025, along with the auditor's report. The document references regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulations 29 and 30, which pertain to disclosures about board meetings and material events. The document is an announcement of a board meeting and the agenda items to be discussed, not the financial results or auditor's report themselves. The document length is short (1967 characters) and it does not contain any financial data or detailed reports. Therefore, it is an announcement related to board/management information, specifically about a board meeting and its agenda, which fits the category of Board/Management Information (MANG).
2025-05-17 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-17 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the closure of the trading window in compliance with insider trading regulations. It references the Securities and Exchange Board of India (SEBI) regulations and specifies the trading window closure period around the financial results announcement date. The document does not contain any financial data, report content, or detailed analysis. It is an announcement related to trading restrictions rather than a financial report or earnings release. The document length is short (1661 characters), and it serves as a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.